Last reviewed · How we verify
Cannabis tobacco
At a glance
| Generic name | Cannabis tobacco |
|---|---|
| Sponsor | Centre for Addiction and Mental Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum (NA)
- N-Acetylcysteine for Smoking Cessation in Tobacco and Cannabis Co-Use (PHASE4)
- Addressing Tobacco, E-Cigarette, and Cannabis Waste (NA)
- Combined and Separate Effects of Cannabis and Tobacco: Psychomotor, Subjective and Physiological Outcomes (NA)
- Tobacco-Concurrent Addictions in At-Risk Youth in Ottawa
- Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer
- Alcohol and Cannabis Use Among Pregnant Slovenian Women
- Using Novel Behavioral Economic Measures to Characterize Dual Marijuana and Tobacco Use in Young Adults (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cannabis tobacco CI brief — competitive landscape report
- Cannabis tobacco updates RSS · CI watch RSS
- Centre for Addiction and Mental Health portfolio CI